Research Capital analyst Andre Greg McLeish has reiterated a “Buy” rating and $3.50 price target on Cannara Biotech …
Bringing you TOP Pot Stocks!
Research Capital analyst Andre Greg McLeish has reiterated a “Buy” rating and $3.50 price target on Cannara Biotech …
Copyright © 2026 Cannabis Stocks News